European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 439-446, May 2010

Super-extended (D3) lymphadenectomy in advanced gastric cancer

  • F. Roviello

      Affiliations

    • Department of Human Pathology and Oncology, Unit of Surgical Oncology, University of Siena, ITT, Istituto Toscano Tumouri, Italy
  • ,
  • C. Pedrazzani

      Affiliations

    • Department of Human Pathology and Oncology, Unit of Surgical Oncology, University of Siena, ITT, Istituto Toscano Tumouri, Italy
    • Corresponding Author InformationCorresponding author. Dipartimento di Patologia Umana e Oncologia, Sezione di Chirurgia Oncologica, Policlinico ‘Le Scotte’, 53100 Siena, Italy. Tel.: +39 577 585156; fax: +39 577 233337.
  • ,
  • D. Marrelli

      Affiliations

    • Department of Human Pathology and Oncology, Unit of Surgical Oncology, University of Siena, ITT, Istituto Toscano Tumouri, Italy
  • ,
  • A. Di Leo

      Affiliations

    • Department of General Surgery, University of Verona, Italy
  • ,
  • S. Caruso

      Affiliations

    • Department of Human Pathology and Oncology, Unit of Surgical Oncology, University of Siena, ITT, Istituto Toscano Tumouri, Italy
  • ,
  • S. Giacopuzzi

      Affiliations

    • Department of General Surgery, University of Verona, Italy
  • ,
  • G. Corso

      Affiliations

    • Department of Human Pathology and Oncology, Unit of Surgical Oncology, University of Siena, ITT, Istituto Toscano Tumouri, Italy
  • ,
  • G. de Manzoni

      Affiliations

    • Department of General Surgery, University of Verona, Italy

Accepted 22 March 2010.

Abstract 

Purpose

To analyze our experience with D3 lymphadenectomy in the treatment of advanced GC with specific reference to post-operative morbidity and mortality, incidence of para-aortic node (PAN) metastases, and long-term prognosis.

Methods

Short- and long-term results of D3 lymphadenectomy were analyzed in 286 patients with advanced GC.

Results

PAN metastases were demonstrated in 37 patients. PAN involvement was significantly higher in upper third tumours (29%) compared to middle and lower third (7%; P < 0.001). Eighty patients developed post-operative complications, being pulmonary disorders (6%), abdominal abscesses (4.5%) and pancreatic fistulas (3%) the most frequently observed. In-hospital mortality was 2%. Overall 5-year survival rate for R0 pT2-4 patients was 52%. When considering survival in relation to nodal involvement, both pN3 and non-regional lymph node metastases (M1a) patients showed a chance of long-term survival: 5-year survival was 31% for pN3 and 17% for M1a cases. Furthermore, the 5-year survival rate was remarkably high (about 60%) even in pN2 and pN3 subsets when no serosal invasion (pT2) was demonstrated.

Conclusions

D3 lymphadenectomy could be further explored in specialized centers for curative surgery of advanced GC, especially for upper third tumours, providing that an acceptable morbidity and no increase in mortality can be offered.

Keywords: Gastric cancer, Surgery, D3 Lymphadenectomy, Prognosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(10)00064-8

doi:10.1016/j.ejso.2010.03.008

European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 439-446, May 2010